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ABSTRACT
Objectives: We aimed to assess the feasibility of a text messaging intervention by determining the proportion of
emergency department (ED) patients who responded to prompted home blood pressure (BP) self-monitoring and
had persistent hypertension. We also explored the effect of the intervention on systolic blood pressure (sBP) over
time.
Methods: We conducted a randomized, controlled trial of ED patients with expected discharge to home with
elevated BP. Participants were identified by automated alerts from the electronic health record. Those who
consented received a BP cuff to take home and enrolled in the 3-week screening phase. Text responders with
persistent hypertension were randomized to control or weekly prompted BP self-monitoring and healthy behavior
text messages.
Results: Among the 104 patients enrolled in the ED, 73 reported at least one home BP over the 3-week run-in
(screening) period. A total of 55 of 73 reported a home BP of ≥140/90 and were randomized to SMS intervention
(n = 28) or control (n = 27). The intervention group had significant sBP reduction over time with a mean drop of
9.1 mm Hg (95% confidence interval = 1.1 to 17.6).
Conclusions: The identification of ED patients with persistent hypertension using home BP self-monitoring and
text messaging was feasible. The intervention was associated with a decrease in sBP likely to be clinically
meaningful. Future studies are needed to further refine this approach and determine its efficacy.
A related article appears on page 584.
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Hypertension is the most prevalent modifiable car-diovascular risk factor,1–5 with treatment reduc-
ing cardiovascular disease and all-cause mortality.5
Hypertension is common in the United States affect-
ing 78 million adults.6 Hypertension control remains
well below the Healthy People 2020 goal.7 While
blood pressure (BP) control needs improvement in the
overall U.S. adult population, uncontrolled hyperten-
sion is even more common among the uninsured and
working age Americans.6,8–10 New approaches to
hypertension treatment are needed that focus on these
difficult to reach populations to achieve health equity.
Currently, there are 136 million emergency depart-
ment (ED) visits per year—nearly all have at least one
BP measured and recorded. About 20% of working age
Americans had an ED visit in the past year11 and the
uninsured and Medicaid beneficiaries are high-volume
ED users. Even though these high-risk patient groups
are generally not presenting to the ED for hypertension,
the ED visit provides a unique opportunity to engage
them in chronic disease management. However, there is
some concern that ED BP readings may be falsely ele-
vated due to pain or anxiety of the ED visit.12
In this age of electronic health records (EHRs) and
mobile health, it may be possible for the ED to
become an active partner in efficient chronic disease
management by programming the EHR to identify
hypertensive patients and dispense a mobile health
behavioral intervention. Text messaging offers an
appealing option for behavioral interventions, given its
popularity in underserved populations, low cost, ease
of adoption, scalability, and ability to reach people in
real time yet remain flexible and convenient.13
In this context, we designed Reach Out ED—a
pilot trial of an ED-based, mobile health, multicompo-
nent, health theory-based, behavioral intervention to
reduce BP for future testing in a large scale, random-
ized controlled trial (see Data Supplement S1, available
as supporting information in the online version of this
paper, which is available at http://onlinelibrary.wiley.c
om/doi/10.1111/acem.13691/full). The overarching
aim was to develop an automated, low-human-
resource, ED-based intervention to improve BP in an
at-risk population. A key barrier to ED-based interven-
tions is determining patient eligibility for such an
intervention. Thus, our primary objective was to deter-
mine the feasibility of our intervention. Specifically, we
sought to determine the proportion of ED patients
who, after discharge to home, responded to prompted
BP self-monitoring and the proportion of responses
with persistently elevated BP over 140/90 mm Hg.
Our secondary objective was to explore the effect of
the Reach Out intervention on BP over time.
METHODS
Study Design
Briefly, Reach Out ED was a randomized feasibility
study. We enrolled hypertensive patients meeting eligi-
bility at the University of Michigan Health System
ED, which at the time had an approximate yearly
patient volume of 70,000 adult patients per year.1 We
prospectively identified patients using EHR-based auto-
matic alert system that notified the study team mem-
bers to the presence of potentially eligible patients.
These were programmed in the EPIC (EPIC Systems)
EHR using best practice alerts that automatically sent
a page to a study team member and placed the visit
ID in a research inbasket within EPIC. We have previ-
ously used automated EHR alerts to identify eligible
research patients in real time in the ED.14,15 Following
initial recruitment, we randomized those persistently
hypertensive after 3 weeks either into the text messag-
ing intervention or into standard care. The primary
objective was to determine the proportion of ED
patients who, after discharge to home, respond to text
reminders with their home assessed BP and the pro-
portion of responses with persistently elevated BP
(>140/90 mm Hg). We have included the study proto-
col and consent form in Data Supplement S2
(available as supporting information in the online
version of this paper, which is available at http://
onlinelibrary.wiley.com/doi/10.1111/acem.13691/full).
We report these results in accordance with the CON-
SORT extension for pilot and feasibility trials and the
relevant checklist is also included in Data Supplement
S2.16
Study Population
Adult ED patients were eligible if they had a docu-
mented systolic BP (sBP) of ≥160 mm Hg or a dias-
tolic BP of ≥100 mm Hg, were likely to be discharged
from the ED, and possessed a mobile phone with text
messaging available. We excluded patients who were
critically ill, otherwise unable to give informed con-
sent, incarcerated/institutionalized residents, pregnant,
or had a preexisting condition that made follow-up for
4 months unlikely. All materials and text messages
were created in English; thus, participants were
excluded if they could not read English. Since patients
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were initially entered into a screening phase and ran-
domized after responding during this 3-week period,
the study personnel who were conducting recruitment
were blinded to treatment group assignment.
Randomization
Once enrolled, but prior to randomization, partici-
pants underwent a screening phase to determine
whether they had persistent hypertension (Figure 1)
defined as BP of ≥140/90, based on the prevailing
definition at the time the study was designed. The goal
of this screening phase was to enrich the population
receiving the intervention by allowing the design to
focus on participants who were willing to respond and
had persistent elevated BP. During the 3-week screen-
ing phase, participants received weekly text messages
that solely requested their BP. Each week the text-mes-
saging system made three attempts to prompt the par-
ticipant to text back his/her BP. Participants who
responded at least one time and had persistent hyper-
tension (any reported measurement of sBP ≥ 140 or a
diastolic BP ≥ 90) were randomized. Participants who
either did not respond at all or did not report a quali-
fying BP were not randomized. The screening phase
allowed the study to focus resources on participants
most likely to benefit. Randomly permuted blocks of 4
and 6 were generated at randomization.org by WJM
and assignments were made for up to 150 partici-
pants. At the time of initial enrollment, the study staff
recruiting participants did not have access to the ran-
domization assignment. When participants in the
screening phase met the eligibility criteria for text-mes-
saging response and persistent hypertension, they were
initiated on either the intervention or the control path-
way by the project manager.
Study Interventions
All participants enrolled in the study were given an
automatic SureLife 860211 wrist BP cuff, American
Heart Association brochures about hypertension and
received a text message 1 day/week for 3 weeks
prompting the participant to text in his/her BP. Dur-
ing the subsequent 3 months, the intervention group
received healthy behavior text messages and weekly
reminders to text back their BP. The healthy behavior
text messages addressed the most important lifestyle
interventions to reduce BP: salt reduction, increased
fruit and vegetable intake, and increased physical activ-
ity (see Data Supplement S1).1,17–19 In addition to
these generic health messages, targeted text messages
based on whether the subject took an antihypertensive
medication and had a primary care physician were pro-
vided. For example, for participants taking antihyper-
tensive medications, text messages also addressed
medication adherence (e.g., pillboxes, schedules).20
Participants received weekly text message prompts to
check and text their BP back. A tailored message com-
paring their recent BP to their enrollment BP was
then sent back to the subject. The control group
received no further text messages and were instructed
to follow up with their primary care doctor for treat-
ment. All participants received a text message
3 months after randomization requesting a final self-
reported BP (Figure 1). Additional details regarding
the theory behind the intervention and the content
and procedure for the text messaging are provided in
Data Supplement S2.
Study Endpoints/Outcome
The primary study endpoint was the proportion of ED
patients who, after discharge to home, responded to
prompted BP self-monitoring and had persistent hyper-
tension defined as BP of ≥140/90 mm Hg. Among
those meeting the primary endpoint who were then
randomized to the next phase, the secondary endpoint
was self-reported sBP 4 months from the time of
enrollment. The primary endpoint was chosen to
assess study feasibility.
Figure 1. Overview of study design. BP = blood pressure.
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Sample Size and Statistical Analysis
We defined the maximum sample size as 150. We
planned to accrue until the end of the academic year
related to resource availability even if the maximum
sample size was not reached. Our primary aim was to
determine if the proportion of participants remaining
Figure 2. Participant screening and flow. BP = blood pressure.
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hypertensive within the 3-week screening phase was at
least 33% based on our belief that this would be a rea-
sonable yield for distribution of BP monitoring
devices. The 95% confidence interval (CI) for a one-
sample proportion (33%) of a total sample size of 150
is 25.5% to 40.5% (binomial method without continu-
ity correction). Therefore, if the observed proportion
was greater than or equal to 25.5% we would con-
clude that the primary hypothesis of the trial (that pro-
portion of participants with persistent hypertension
measured within 3 weeks is at least 33%) has been
achieved within a reasonable degree of certainty. For
the secondary analyses, we calculated the mean change
in BP, along with the 95% CI for the change from
the baseline randomization phase measures to final
measurement for the intervention and control groups.
We did not compare the means or conduct a hypothe-
sis test on them. The BP change analyses were
intended to assess whether the intervention was in a
zone of promise. We did not define this formally a
priori but in general we believed that a reduction in
sBP of around 3 to 5 mm Hg would be likely to be
clinically meaningful based on past cardiovascular tri-
als.21 As such, estimating whether our intervention
was potentially consistent with this magnitude of effect
was the intent of these analyses.21 We used the med-
ian of the up to three home BP measurements during
the screening phase as the baseline BP in qualifying
participants.
Post Hoc and Graphical Analyses
A large proportion of the final outcomes were missing.
We addressed this through graphical exploration of
the data and using a last observation carried forward
(LOCF) approach. First, we graphed the change from
ED initial sBP from the initial visit in the ED, to the
median of the screening phase, and finally to the end
of study. Second, we graphed each recorded sBP (base-
line, final, or subject reported), for each participant by
week of the study. This depicted how many readings
were at markedly high or low levels. Third, for sub-
jects with a missing final visit, we imputed the value
by taking the last recorded BP from the study and car-
rying it forward—LOCF. For example, a subject with
an ED sBP of 247, who did not respond to any texts,
would have 247 entered as the final measurement for
zero change. We estimated the means and standard
errors for the treatment and control groups. It is
important to note that no LOCF imputations were
used for the graphical analyses reported above. Finally,
we stratified the cohort by whether the subjects were
taking one or more BP medicines at the time of initial
enrollment and estimated the mean change in SBP
and standard errors by treatment and control groups
as well. Given the small sample size, we only con-
ducted this stratified analysis using the LOCF,
imputed population.
Safety and Adverse Event Tracking
Education during initial enrollment included a warn-
ing that patients should contact their clinician directly
or call 9-1-1 if they have any urgent questions or
health problems that should be addressed before their
next scheduled visit. Participants self-reporting a weekly
BP of >180/110 were sent an automated message
advising immediate contact with a doctor to have their
BP checked as they are at high risk. Additionally, any
participants who spontaneously sent in messages (such
as questions or comments) received an immediate
automated message advising them that if they have
questions they should contact their doctor or in an
emergency call 9-1-1. We used a study-specific adverse
event reporting plan. We only collected and reported
serious adverse events that were definitely, probably,
or possibly related to the study (e.g., ED visit from cuff
injury).
Human Subjects Protection
The protocol was approved by the University of Michi-
gan Medical School Institutional Review Board
(IRBMED) with approval number HUM00091668.
Written informed consent was obtained from all
participants.
RESULTS
Characteristics of Cohort
During the 7-month enrollment period between Octo-
ber 2014 and April 2015, over 9,300 patients with
elevated BP were identified through the EHR-based
automatic alerts. A total of 1,908 of these had data
on eligibility abstracted. Of these, 169 were
approached and 104 patients enrolled (64%) (Fig-
ure 2). The enrolled cohort was primarily white and
insured and had a history of hypertension (Table 1).
Follow-up of the last participant occurred in August
2015. Enrollment ended prior to the recruitment of
150 participants since it was the end of the academic
year and this was a preplanned criterion for termina-
tion of recruitment.
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Proportion Responding With Persistent
Hypertension: Primary Endpoint Results
A total of 73 of the 104 enrolled participants
responded to at least one text during the screening
phase representing 70% (95% CI = 60% to 78%) of
our cohort. For our primary endpoint, 55 of 104
enrolled patients (53%, 95% CI = 43% to 62%)
responded and were hypertensive; this exceeded our
predefined minimum threshold of 25.5%. No
participants reported any adverse effects attributable to
the study protocol.
Utilization of Text Messaging
During the 3-week screening phase, 43 participants
texted BP measurements for 3 weeks, 25 texted BPs for
2 weeks, and seven texted a BP one of the weeks only.
Within the treatment group receiving weekly text
prompted self-monitoring, we observed a uniform
Table 1
Characteristics of Participants at Baseline
Control (n = 27) Intervention (n = 28)
Enrolled, Not
Randomized (n = 49)
Age (years) 50 (12) 49 (13) 48 (13)
Female 9 (33) 15 (54) 30 (61)
Hispanic 2 (7) 0 (0) 3 (6)
Race
Asian 0 (0) 0 (0) 1 (2)
Black/African American 5 (19) 7 (25) 12 (24)
White 21 (78) 20 (71) 32 (65)
Other, NA, or not disclosed 0 (0) 1 (4) 5 (10)
Desired text frequency
Once every other day 16 (59) 12 (43) 27 (55)
Once per day 9 (33) 14 (50) 18 (37)
Twice per day 2 (7) 2 (7) 4 (8)
Health insurance (multiple types could be selected)
Private 17 (63) 19 (68) 22 (45)
Medicaid 2 (7) 3 (11) 11 (22)
Medicare 4 (15) 3 (11) 9 (18)
Uninsured 0 (0) 0 (0) 2 (4)
Other (all wrote in a form of private insurance) 7 (26) 6 (21) 13 (27)
Routine place for primary medical care 22 (81) 28 (100) 44 (90)
Previous diagnosis of hypertension 20 (74) 21 (75) 35 (71)
Prior hospitalization for hypertension 4 (15) 2 (7) 6 (12)
Prior medication for hypertension 13 (48) 17 (61) 26 (53)
Current number of hypertension medications taking
0 18 (67) 12 (43) 25 (51)
1 4 (15) 10 (36) 14 (29)
2 1 (4) 6 (21) 4 (8)
3 1 (4) 0 (0) 3 (6)
4 1 (4) 0 (0) 2 (4)
5 2 (7) 0 (0) 0 (0)
Smoke cigarettes 6 (22) 7 (25) 3 (6)
Most commonly used communication method
In-person conversations 5 (19) 6 (21) 16 (33)
Internet/social media 1 (4) 2 (7) 3 (6)
Other 1 (4) 0 (0) 1 (2)
Phone calls 13 (48) 10 (36) 18 (37)
Text messages 7 (26) 10 (36) 11 (22)
Characteristics of each of the groups, based on enrollment status and group assignment. Data are reported as mean (SD) or n (%).
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distribution of text responses with the most frequent
number of text responses 6 of the 12 weeks (Figure 3).
Change in sBP Over Time: Secondary
Endpoint Results
We illustrate the change in sBP or loss to follow-up
over the course of the study for all 104 participants in
Figure 4. We indicate whether the patient reported
taking BP medications at baseline and show how
much the BP changed from screening to randomiza-
tion, and from randomization to the final visit. Very
few self-reported BPs were over the threshold to
prompt a warning to urgently see a doctor (Figure 5).
The intervention group had significant sBP reduc-
tion over time with a mean drop of 9.1 mm Hg (95%
CI = 1.1 to 17.6; Table 2). The mean drop for the
control group was lower, but substantial at 6.6 mm
Hg (95% CI = –2.4 to 15.6), although the CI for this
change crossed zero. When we repeated the analysis
using the LOCF imputation procedure, we observed
similar drops in BP over time across the groups. The
stratified analyses using the LOCF data demonstrated
that current BP medication use may be important, as
the control group without current medication had
almost no change in BP, whereas the control and
intervention subjects on medication had drops of 11.2
and 9.5 mm Hg, respectively.
Adverse Events
We did not observe any serious adverse events during
the course to the study that met the definition in our
prespecified IRB-approved safety reporting plan.
DISCUSSION
In this pilot trial of an ED-based, mobile health, multi-
component, health theory–based, behavioral interven-
tion to reduce BP, we found that ED recruitment of
patients who later had persistently elevated BP is feasi-
ble. We found that 53% of participants who enrolled
had persistent hypertension during the 3 weeks after
their ED visit. Our findings show the feasibility of
automated, real-time EHR alerts to identify possibly eli-
gible ED patients and confirm the feasibility of the
recruitment strategy and text-prompted BP self-monitor-
ing to assess subject eligibility. These findings were
instrumental in the successful NIH funding of a lar-
ger-scale phase II trial evaluating a multicomponent
text-messaging intervention for patients with elevated
BPs in the ED. Our post hoc analyses demonstrated
potential heterogeneity of sBP trajectory following the
ED visit based on whether the participants reported
being on BP medications at time of initial enrollment.
In our follow-up study, we plan to use this as a stratifi-
cation variable at the time of randomization and we
will hopefully gain better understanding regarding the
different prognosis for patients with and without prior
antihypertensive treatment.
Our findings suggest that the ED can be a valuable
partner in hypertension screening particularly among
the working age population who can be difficult to
reach and derive substantial benefit from hypertension
control. Our automated alerts identified over 9,000
potentially eligible participants in 7 months. Further-
more, of those approached over 50% agreed to enroll-
ment in the screening phase of our trial. Additionally,
0
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Frequency of Weekly Reported BPs Returned
Figure 3. Distribution of BP responses in the intervention group. Within the intervention group, the number of weeks that a BP was texted
back in response to the system prompt. BP = blood pressure; sBP = systolic blood pressure.
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Figure 5. All study BPs over time. All sBPs, by week of study. Week 1 is the baseline in the ED, Weeks 2 to 4 are the screening period,
Weeks 5 to 16 are weekly text messaging–based responses in the intervention group, and Week 17 is the final in-person follow-up visit.
Patients who were not eligible (due to SBP < 140) or did not respond to texts are indicated with a plus sign, the intervention group is indi-
cated with triangles, and the control group with circles. BP = blood pressure; sBP = systolic blood pressure.
Figure 4. Blood pressure trends and early dropout over study period. Each of the 104 patients grouped from left to right by those who did
not qualify for randomization, the intervention group and the control group. Within each group participants are arranged from left to right in
order of highest ED SBP. Red bars depict the change in sBP from ED visit to median screening phase sBP for patients taking BP medica-
tions; the blue bars represent this change for patients not taking BP medications. For patients who never returned any texts, the circles rep-
resent the ED sBP for patients taking BP medications and the triangles represent each subject who was not taking BP medications. The
narrower, yellow bars represent the change in sBP from the screening phase to the final visit for the intervention group. Subject 73 is an
example of a case where the sBP was higher at the final visit. The narrower, purple bars represent the change from screening phase to end
of study for the control group. Some subjects with median sBP lower than 140 from the screening phase depicted above were randomized.
In one case, a participant had a diastolic BP over 90, in the other cases at least one sBP measurement was 140 or above. BP = blood pres-
sure; sBP = systolic blood pressure.
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we found that about one-half of participants who were
enrolled in the ED had persistent hypertension
defined as ≥140/90. If current definitions of hyperten-
sion were used, the proportion of participants with
persistent hypertension would likely increase. Our
findings are concordant with a single-center observa-
tional study in an urban ED that found that 51% of
hypertensive patients remained hypertensive 1 week
after their ED visit.22 There are many competing
demands on the ED workforce many of which out-
weigh chronic disease management. Thus, Reach Out
was designed with this in mind. With its automated
patient identification via EHR, if the Reach Out inter-
vention was effective the ED workforce would only
need to dispense a BP cuff. This practical approach
increases the possibility of future dissemination and
implementation if future studies confirm this approach
can meaningfully reduce BP.
Little data exist to guide the management of ED
patients with asymptomatic hypertension. While guide-
lines recommend BP screening,23 the guidance for
management of asymptomatic hypertension in the ED
is based on consensus opinion, which varies widely
from no intervention, referral for outpatient follow up,
or initiation of antihypertensives.24 We found reduc-
tions in BP over time in both the Reach Out interven-
tion and the control groups; however, only the
intervention group CI excluded zero change or
worsening.
The use of weekly prompted BP self-monitoring
both for study inclusion and as a component of the
intervention is novel. We found variable adherence to
returning text messages in our treatment group,
despite using an enrichment strategy to increase the
likelihood of including patients who would be willing
to respond. Mobile health interventions to reduce BP
have shown promise, but are limited by short duration
of follow-up, data on the optimal intervention compo-
nents and delivery, and absence of rigorous clinical
trial design.25 The Reach Out pilot and its future ran-
domized trial will fill some of these scientific gaps.
LIMITATIONS
This work has several important limitations. Our
results only apply to participants who are expected to
be discharged to home from the ED and thus cannot
be extrapolated to participants who were admitted to
the hospital. There were several participants with miss-
ing data for the final measurement of sBP, although
the focus of this study was to determine how many
participants would respond to text requests for their
BP and remain hypertensive and therefore be eligible
for randomization. The greater loss to follow-up in the
control arm informed the design of our follow-up
study. Specifically, in our ongoing phase II trial we
provide patient incentives for follow-up and request
self-monitored BPs from all participants in all arms of
the trial. In our pilot, all potentially eligible partici-
pants were not approached for enrollment. However,
times of research assistant availability were varied and
should therefore reflect the overall ED population at a
suburban academic ED. We limited our enrollment to
an academic year, as the pilot study had limited fund-
ing and we utilized college students gaining academic
credit as our primarily recruiters. In addition, patients
seek care for different reasons in diverse settings and
our study was conducted at a single center in one
community. For our secondary analysis, we used a
LOCF approach to missing data. This may be conser-
vative, although it is possible that subjects who
dropped out had improving or worsening BP so it is
not clear the direction of bias or noise this approach
is introducing. The application of the LOCF imputa-
tion resulted in a difference in means for both groups
that were smaller with wider CIs, yet still was within a
promising zone for the treatment group. Given the
methods we used to tailor our text messages, we
focused on an English-speaking population only. In
addition, we did not systematically assess whether our
intervention induced ED visits that did not result in a
Table 2
BP Changes: Baseline Versus Final Visit
No. Mean (mm Hg) SEM 95% CI
sBP reduction (final minus baseline) with final visit
Intervention 14 9.1 4.1 1.1 to 17.1
Control 16 6.6 4.6 –2.4 to 15.6
sBP reduction (final minus baseline) LOCF
All randomized
Intervention 28 8.7 2.8 3.2 to 14.2
Control 27 4.1 3 –1.8 to 10
No reported BP medications
Intervention 28 7.7 3.5 0.8 to 14.6
Control 27 0.5 3.2 –5.8 to 6.8
Reported BP medications
Intervention 28 9.5 4.2 1.3 to 17.7
Control 27 11.2 3.5 4.3 to 18.1
Results of BP change analyses. Any negative numbers represent
an increase in BP.
BP = blood pressure; LOCF = last observation carried forward;
sBP = systolic blood pressure.
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change in hypertension management—although ED
utilization of participants will be monitored in our fol-
low-up trial. We used wrist cuffs to address patient
preference and limit the need to size upper arm cuffs.
Wrist cuffs may not be as accurate as upper arm cuffs;
however, it is unclear whether they would be systemati-
cally over- or underestimating arterial BP; in addition,
we use the cuff over time within patient and that
could mitigate the influence of this potential problem.
We did not collect individual data on self-efficacy or
medication adherence. Our cohort was majority white
and almost entirely insured, which may limit generaliz-
ability to other populations. Finally, within this feasi-
bility study, we did not collect data regarding the
initiation of new medications or dosage changes. In
our ongoing clinical trial, we plan to routinely query
participants regarding the timing and frequency of
changes in their medications, along with assessing
medication adherence.
CONCLUSIONS
In conclusion, weekly prompted blood pressure self-
monitoring is feasible and can identify ED patients
with persistent hypertension who may benefit from a
hypertension intervention. Further research is needed
to determine the efficacy of the ED-based, mobile
health, multicomponent, health theory–based behav-
ioral intervention to reduce BP.
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